Menu
Back to Journals » Biologics: Targets and Therapy » Volume 5 » default
Biologics: Targets and Therapy
ISSN: 1177-5491
- View all (494)
- Volume 17, 2023 (15)
- Volume 16, 2022 (18)
- Volume 15, 2021 (40)
- Volume 14, 2020 (13)
- Volume 13, 2019 (17)
- Volume 12, 2018 (19)
- Volume 11, 2017 (14)
- Volume 10, 2016 (18)
- Volume 9, 2015 (17)
- Volume 8, 2014 (27)
- Volume 7, 2013 (28)
- Volume 6, 2012 (46)
- Volume 5, 2011 (9)
- Volume 4, 2010 (31)
- Volume 3, 2009 (45)
- Volume 2, 2008 (89)
- Volume 1, 2007 (48)
Archive: Volume 5, 2011
Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions
Almer G, Saba-Lepek M, Haj-Yahya S, Rohde E, Strunk D, Fröhlich E, Prassl R, Mangge H
Biologics: Targets and Therapy 2011, 5:95-105
Published Date: 7 September 2011
Current neoadjuvant treatment options for HER2 positive breast cancer
Abdel-Razeq H, Marei L
Biologics: Targets and Therapy 2011, 5:87-94
Published Date: 9 August 2011
Gut microbiota: next frontier in understanding human health and development of biotherapeutics
Prakash S, Rodes L, Coussa-Charley M, Tomaro-Duchesneau C
Biologics: Targets and Therapy 2011, 5:71-86
Published Date: 11 July 2011
The role of stem cells in tumor targeting and growth suppression of gliomas
Eskandary H, Basiri M, Nematollahi-Mahani SN, Mehravaran S
Biologics: Targets and Therapy 2011, 5:61-70
Published Date: 5 April 2011
A combined Phase I and II open-label study on the immunomodulatory effects of seaweed extract nutrient complex
Stephen P Myers, Joan O'Connor, J Helen Fitton, et al
Biologics: Targets and Therapy 2011, 5:45-60
Published Date: 15 February 2011
An update on belimumab for the treatment of lupus
Aikaterini Thanou-Stavraki, Amr H Sawalha,
Biologics: Targets and Therapy 2011, 5:33-43
Published Date: 14 February 2011
Update on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus
Michael Sticherling
Biologics: Targets and Therapy 2011, 5:21-31
Published Date: 14 February 2011
Vitamins D, C, and E in the prevention of type 2 diabetes mellitus: modulation of inflammation and oxidative stress
Bibiana Garcia-Bailo, Ahmed El-Sohemy, Pierre S Haddad, et al
Biologics: Targets and Therapy 2011, 5:7-19
Published Date: 19 January 2011
Bevacizumab in the treatment of ovarian cancer
Ramez N Eskander, Leslie M Randall
Biologics: Targets and Therapy 2011, 5:1-5
Published Date: 11 January 2011